To compare the level of lytic viral protein in tumors with T1 versus T2 EBV infection, we initially performed IHC studies using antibodies that detect either BZLF1 (Z), an immediate-early lytic viral protein, or gp350 (a late lytic structural viral glycoprotein). This evidence concerns the gene ART4 and Epstein-Barr virus infection.